Viewing Study NCT07101159


Ignite Creation Date: 2025-12-24 @ 2:48 PM
Ignite Modification Date: 2025-12-27 @ 8:14 PM
Study NCT ID: NCT07101159
Status: NOT_YET_RECRUITING
Last Update Posted: 2025-08-03
First Post: 2025-07-25
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Dalpiciclib as Adjuvant Therapy for HR-positive/HER2-negative Early-stage Patients
Sponsor: Fujian Cancer Hospital
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module